Advertisement

Canadian Journal of Public Health

, Volume 105, Issue 3, pp e198–e202 | Cite as

Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada

  • Fiona G. KouyoumdjianEmail author
  • Liviana M. Calzavara
  • Lori Kiefer
  • Cheryl Main
  • Susan J. Bondy
Quantitative Research

Abstract

OBJECTIVES: To describe the prevalence of drug use in males in a provincial detention centre during the year before incarceration and to examine the association between socio-demographic and behavioural factors and drug use.

METHODS: In 2009, 500 adult males completed a survey after admission to a provincial detention centre in Ontario. Past-year prevalence rates were calculated for the use of opioids, cocaine, crack and methamphetamine, and by route of administration. Bivariate logistic regression was used to examine associations between drug use and socio-demographic and behavioural factors.

RESULTS: More than 56% of participants reported use of opioids, cocaine, crack or methamphetamine in the previous year. Risk factors for blood-borne and sexually transmitted infections were commonly reported for the previous year: 12.2% had injected drugs, 78.0% had had unprotected sex, and 48.0% had had more than one sexual partner. In unadjusted analyses, participants who were older than 24 years were more likely to have used any drugs and to have injected drugs in the previous year.

CONCLUSIONS: This study provides the first Canadian data in the past decade on drug use by recently incarcerated adults. We found that drug use and behaviours that increase the risk of transmission of sexually transmitted and blood-borne infections remain very common in this population. Incarceration provides an opportunity to provide services and links to programs for people who use drugs, which could decrease drug-related harms to individuals and society.

Key Words

Prisons drug use disorders substance use disorders street drugs 

Résumé

OBJECTIFS: Décrire la prévalence de la consommation de drogue dans la population carcérale masculine d’un centre de détention provincial durant l’année précédant l’incarcération et examiner l’association entre les facteurs sociodémographiques et comportementaux et la consommation de drogue.

MÉTHODE: En 2009, 500 hommes adultes ont rempli un questionnaire après leur arrivée dans un centre de détention provincial en Ontario. Les taux de prévalence de l’année antérieure ont été calculés pour la consommation d’opioïdes, de cocaïne, de crack et de méthamphétamine, et selon la voie d’administration de ces drogues. Une régression logistique bivariée a servi à examiner les liens entre la consommation de drogue et les facteurs sociodémographiques et comportementaux.

RÉSULTATS: Plus de 56 % des participants ont déclaré avoir consommé des opioïdes, de la cocaïne, du crack ou de la méthamphétamine au cours de l’année antérieure. Des facteurs de risque d’infections transmissibles sexuellement et par le sang ont souvent été déclarés pour l’année antérieure: 12,2 % s’étaient injecté de la drogue, 78 % avaient eu des rapports sexuels non protégés, et 48 % avaient eu plus d’une ou d’un partenaire sexuel. Selon nos analyses non ajustées, les participants de plus de 24 ans étaient plus susceptibles d’avoir consommé l’une de ces drogues et de s’être injecté de la drogue au cours de l’année antérieure.

CONCLUSIONS: Cette étude présente les premières données canadiennes de la dernière décennie sur la consommation de drogue chez des adultes récemment incarcérés. Nous constatons que la consommation de drogue et les comportements qui augmentent le risque de transmission des infections transmissibles sexuellement et par le sang sont encore très courants dans cette population. L’incarcération présente la possibilité d’offrir des services aux personnes qui consomment de la drogue et de les aiguiller vers des programmes, ce qui pourrait réduire les méfaits liés à la drogue au niveau individuel et sociétal.

Mots Clés

prison troubles dus à la consommation de drogue troubles liés à une substance drogues de rue 

References

  1. 1.
    Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: A systematic review. Addiction 2006;101(2):181–91.CrossRefGoogle Scholar
  2. 2.
    Fazel S, Baillargeon J. The health of prisoners. Lancet 2011;377(9769):956–65.CrossRefGoogle Scholar
  3. 3.
    Kanato M. Drug use and health among prison inmates. Curr Opin Psychiatr 2008;21:252–54.CrossRefGoogle Scholar
  4. 4.
    Kinner SA, Forsyth S, Williams G. Systematic review of record linkage studies of mortality in ex-prisoners: Why (good) methods matter. Addiction 2013;108(1):38–49.CrossRefGoogle Scholar
  5. 5.
    Statistics Canada. Adult Correctional Services, Admissions to Provincial, Territorial and Federal Programs (Canada). 2012. Available at: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/legal30aeng.htm (Accessed November 4, 2013).Google Scholar
  6. 6.
    Zakaria D, Thompson JM, Jarvis A, Borgatta F. Summary of Emerging Findings from the 2007 National Inmate Infectious Diseases and Risk-Behaviours Survey. Correctional Service Canada, 2010.Google Scholar
  7. 7.
    Johnson S, MacDonald SF, Cheverie M, Myrick C, Fischer B. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada. Drug Alcohol Depend 2012;124(1–2):172–76.CrossRefGoogle Scholar
  8. 8.
    Ford PM, Pearson M, Sankar-Mistry P, Stevenson T, Bell D, Austin J. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen’s University HIV Prison Study Group. QJM 2000;93(2):113–19.CrossRefGoogle Scholar
  9. 9.
    Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M, Wallace E, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003;98(9):1257–65.CrossRefGoogle Scholar
  10. 10.
    Calzavara L, Ramuscak N, Burchell AN, Swantee C, Myers T, Ford P, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ 2007;177(3):257–61.CrossRefGoogle Scholar
  11. 11.
    Buxton JA, Rothon D, Durigon M, Lem M, Tu AW, Remple VP, et al. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia. Can J Public Health 2009;100(2):121–24.PubMedGoogle Scholar
  12. 12.
    Dufour A, Alary M, Poulin C, Allard F, Noel L, Trottier G, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996;10(9):1009–15.CrossRefGoogle Scholar
  13. 13.
    Martin RE, Gold F, Murphy W, Remple V, Berkowitz J, Money D. Drug use and risk of bloodborne infections: A survey of female prisoners in British Columbia. Can J Public Health 2005;96(2):97–101.PubMedGoogle Scholar
  14. 14.
    Poulin C, Alary M, Lambert G, Godin G, Landry S, Gagnon H, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. CMAJ 2007;177(3):252–56.CrossRefGoogle Scholar
  15. 15.
    World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, Switzerland: World Health Organization, 2009.Google Scholar
  16. 16.
    Shoptaw S, Montgomery B, Williams CT, El-Bassel N, Aramrattana A, Metsch L, et al. Not just the needle: The state of HIV-prevention science among substance users and future directions. J Acquire Immune Defic Syndr 2013;63(Suppl 2):S174–78.CrossRefGoogle Scholar
  17. 17.
    Meader N, Li R, Des Jarlais DC, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev 2010;(1):CD007192.Google Scholar
  18. 18.
    Ford PM, Alifo A, Connop PJ, Panaro L, Zoutman D. Seroprevalence of HIV-1 in a male medium security penitentiary–Ontario. Can Commun Dis Rep 1994;20(6):45–47.PubMedGoogle Scholar
  19. 19.
    Kouyoumdjian FG, Main C, Calzavara LM, Kiefer L. Prevalence and predictors of urethral chlamydia and gonorrhea infection in male inmates in an Ontario correctional facility. Can J Public Health 2011;102(3):220–24.PubMedGoogle Scholar
  20. 20.
    Prefontaine RG, Chaudhary, RK. Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in British Columbia. Can Dis Wkly Rep 1990;16(52):265–66.PubMedGoogle Scholar
  21. 21.
    Pearson M, Mistry PS, Ford, PM. Voluntary screening for hepatitis C in a Canadian federal penitentiary for men. Can Commun Dis Rep 1995;21(14):134–36.PubMedGoogle Scholar
  22. 22.
    Ford PM, White C, Kaufmann H, MacTavish J, Pearson M, Ford S, et al. Seroprevalence of hepatitis C in a Canadian federal penitentiary for women. Can Commun Dis Rep 1995;21(14):132–34.PubMedGoogle Scholar
  23. 23.
    Ford PM, White C, Kaufmann H, MacTavish J, Pearson M, Ford S, et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ 1995;153(11):1605–9.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Werb D, Kerr T, Small W, Li K, Montaner J, Wood E. HIV risks associated with incarceration among injection drug users: Implications for prisonbased public health strategies. J Public Health 2008;30(2):126–32.CrossRefGoogle Scholar
  25. 25.
    Fischer B, Rehm J, Patra J, Cruz, MF. Changes in illicit opioid use across Canada. CMAJ 2006;175(11):1385.CrossRefGoogle Scholar
  26. 26.
    Remis R. Modelling the incidence and prevalence of hepatitis C infection and its sequelae in Canada, 2007. Ottawa, ON: Public Health Agency of Canada, 2007.Google Scholar
  27. 27.
    Small W, Kain S, Laliberte N, Schechter MT, O’Shaughnessy MV, Spittal PM. Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Subst Use Misuse 2005;40(6):831–43.CrossRefGoogle Scholar
  28. 28.
    Juergens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis 2009;9(1):57–66.CrossRefGoogle Scholar
  29. 29.
    Dembo R, Dertke M, La Voie L, Borders S, Washburn M, Schmeidler J. Physical abuse, sexual victimization and illicit drug use: A structural analysis among high risk adolescents. J Adolesc 1987;10(1):13–34.CrossRefGoogle Scholar
  30. 30.
    Galea S, Vlahov D. Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration. Public Health Rep 2002;117(Suppl 1):S135–45.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Ireland JL, Higgins P. Behavioural stimulation and sensation-seeking among prisoners: Applications to substance dependency. Int J Law Psychiatry 2013;36(3-4):229–34.CrossRefGoogle Scholar
  32. 32.
    Schulz AJ, Krieger J, Galea S. Addressing social determinants of health: Community-based participatory approaches to research and practice. Health Educ Behav 2002;29(3):287–95.CrossRefGoogle Scholar
  33. 33.
    Haig T. Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison. Can HIV/AIDS Policy Law Rev 2003;8(3):48.Google Scholar

Copyright information

© The Canadian Public Health Association 2014

Authors and Affiliations

  • Fiona G. Kouyoumdjian
    • 1
    Email author
  • Liviana M. Calzavara
    • 2
  • Lori Kiefer
    • 2
    • 3
  • Cheryl Main
    • 4
  • Susan J. Bondy
    • 2
  1. 1.Dalla Lana School of Public HealthTorontoCanada
  2. 2.Dalla Lana School of Public HealthTorontoCanada
  3. 3.Ontario Ministry of Community Safety and Correctional ServicesTorontoCanada
  4. 4.Department of Pathology and Molecular Medicine, Department of MicrobiologyHamilton General HospitalHamiltonCanada

Personalised recommendations